Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,345
  • Shares Outstanding, K 9,438
  • Annual Sales, $ 15,030 K
  • Annual Income, $ -11,140 K
  • EBIT $ -15 M
  • EBITDA $ -15 M
  • 60-Month Beta 6.93
  • Price/Sales 0.79
  • Price/Cash Flow N/A
  • Price/Book 4.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.53
  • Number of Estimates 1
  • High Estimate -0.53
  • Low Estimate -0.53
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -89.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4235 +6.78%
on 02/04/26
2.1800 -30.28%
on 01/15/26
-0.4300 (-22.05%)
since 01/13/26
3-Month
1.4235 +6.78%
on 02/04/26
2.6900 -43.49%
on 01/05/26
-0.9000 (-37.19%)
since 11/13/25
52-Week
1.4235 +6.78%
on 02/04/26
7.9500 -80.88%
on 07/11/25
-2.7300 (-64.24%)
since 02/13/25

Most Recent Stories

More News
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)

The show broadcasts as sponsored programming with national TV commercials from Synergy CHC (NASDAQ:SNYR), NeOnc Technologies (NASDAQ:NTHI), PetVivo (OTCQX:PETV), and YY Group Holdings (NASDAQ:YYGH).

SNYR : 1.6300 (-1.21%)
PETV : 0.7360 (-5.64%)
NTHI : 10.24 (-2.15%)
SDST : 3.42 (+3.01%)
VTIX : 4.83 (+1.26%)
AERT : 0.4830 (-1.23%)
YYGH : 0.2052 (-0.68%)
VVOS : 1.5200 (-1.94%)
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”...

VVOS : 1.5200 (-1.94%)
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street

Twelve months of national and global coverage to include long-form interviews, earned media, television commercials, iconic outdoor billboards, and accredited investor events

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

LITTLETON, Colo., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST

LITTLETON, Colo., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing...

VVOS : 1.5200 (-1.94%)
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) , a leading medical device and technology company specializing in...

VVOS : 1.5200 (-1.94%)

Business Summary

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

See More

Key Turning Points

3rd Resistance Point 1.8742
2nd Resistance Point 1.7993
1st Resistance Point 1.6597
Last Price 1.5200
1st Support Level 1.4452
2nd Support Level 1.3703
3rd Support Level 1.2307

See More

52-Week High 7.9500
Fibonacci 61.8% 5.4569
Fibonacci 50% 4.6867
Fibonacci 38.2% 3.9166
Last Price 1.5200
52-Week Low 1.4235

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar